학술논문
P2.14-33 An Open-Label PET-MRI Study to Determine Brain Exposure of Osimertinib in Patients with EGFR Mutant NSCLC and CNS Metastases
Document Type
Abstract
Author
Source
In Journal of Thoracic Oncology October 2019 14(10) Supplement:S842-S842
Subject
Language
ISSN
1556-0864